Lan’s Story

Lan’s Story

[vc_video link=’https://www.youtube.com/watch?v=ckmQNcicoZ0′]

In Vietnam, due to the lack of specialist in rural areas, a significant number of chronic myeloid leukemia (CML) patients with minimal cash in hand must travel hundreds to thousands of kilometers to reach the hospitals in the city. The expenses for the trip itself is already a challenge for many patients let alone the cost of treatment. But today, there are numerous CML survivors who directly benefit from The Max Foundation’s patient access program to receive their cancer treatment at no cost. A living testimony to the success of our program is Lan.

Lan is a young, enthusiastic, Vietnamese woman living in Ha Noi, who refuses to be ordinary. On World CML Day 2017, Lan decided to let her treatment journey story to be heard. Lan was diagnosed chronic myeloid leukemia when she was 23 years old. Initially, she was hesitant to share her story with anyone. It was kept within the family, as she was scared, weak and lost. With an attitude “Never give up nor abandon hope” she kept searching and successfully found what she looked for – The Max Foundation’s “magical” patient assistance program that would bring her the necessary CML treatment. 11 years later and the innovative program still supports Lan and many other CML patients in Vietnam.

Today Lan is living a happy normal life. Like other people in Vietnam, she goes to work and contributes to society. Because of the benefits of the patient assistance program, and continued stigma against cancer patients, Lan has started sharing her story – starting with this video.

Lan is forever grateful for the government that acknowledges the importance of patient assistance program. With Lan’s advocacy and our ongoing work, we hope to see other sustainable treatment access programs extended to many other patients in need.

Thao Tang is a MaxStation based in Ho Chi Minh City, who is managing Patient Assistant Program and passionate about supporting cancer patients of Vietnam.

Related Articles

  • Congratulations to the 2015 Maximize Life Essay Contest Winners!

    Congratulations to the 2015 Maximize Life Essay Contest Winners!

    Have you visited the 2015 Maximize Life Essay Contest webpage recently? The Max Foundation is honored to share that the 2015 Maximize Life Essay Contest winners are officially released! Three winners in total, one for each of the French, English and Spanish categories, were selected by a panel of highly esteemed judges within the global health community. You may view the complete panel of judges here. We are exceedingly grateful for the valuable time and input provided by each of the judges. With 71 meaningful and authentic personal stories submitted, it was no small task to select only one winner for each language category!

  • With Love in Every Stitch Brings Smiles to the Philippines!

    With Love in Every Stitch Brings Smiles to the Philippines!

    On October 23rd we visited the out-patient department of the Philippine General Hospital to distribute a recent shipment of hats that we had received from With Love in Every Stitch. It was amazingly beautiful to see the faces of small children queuing up to choose the hats they liked. The children were fascinated with the colors and designs of the hats. They gladly tried them on and proudly showed them to their parents and the other children.

  • The Maximize Life Campaign: Asia Pacific Region Patient Groups Are Telling Their Stories.

    The Maximize Life Campaign: Asia Pacific Region Patient Groups Are Telling Their Stories.

    Nothing is more powerful than storytelling, especially when it’s told from a person’s first-hand experience.

    In the Asia Pacific region, we are often known as “shy” community. We do not often share our stories publicly, especially a story about cancer diagnosis. We often have no one to turn to because we do not want our parents to worry; we do not want our children to feel the burden; we do not want to tell our neighbors who might be starting to avoid us because we are diagnosed with cancer.